equitymaster.comFalseFalseVAISHALI PHARMA - Last 8 Quarters |
|
Interim Results |
| No. of Months
Qtr. Ending | 3
Mar-22* | 3
Jun-22* | 3
Sep-22* | 3
Dec-22* | 3
Mar-23* | 3
Jun-23* | 3
Sep-23* | 3
Dec-23* |
Net Sales | Rs m | 254 | 102 | 132 | 201 | 262 | 134 | 126 | 279 |
Other income | Rs m | 6 | 4 | 7 | 5 | 5 | 4 | 3 | 5 |
Turnover | Rs m | 260 | 106 | 139 | 206 | 268 | 138 | 129 | 284 |
Expenses | Rs m | 245 | 80 | 106 | 165 | 255 | 111 | 99 | 249 |
Gross profit | Rs m | 9 | 22 | 26 | 36 | 8 | 23 | 27 | 30 |
Depreciation | Rs m | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Interest | Rs m | 6 | 5 | 5 | 4 | 5 | 4 | 5 | 4 |
Profit before tax | Rs m | 6 | 20 | 27 | 35 | 6 | 21 | 24 | 29 |
Tax | Rs m | 4 | 5 | 7 | 9 | 2 | 5 | 7 | 8 |
Profit after tax | Rs m | 2 | 15 | 20 | 27 | 4 | 16 | 17 | 21 |
Gross profit margin | % | 3.5 | 21.6 | 19.7 | 17.7 | 3.0 | 17.2 | 21.1 | 10.6 |
Effective tax rate | % | 67.9 | 25.0 | 25.0 | 25.0 | 30.1 | 25.2 | 27.8 | 26.3 |
Net profit margin | % | 0.8 | 14.9 | 15.2 | 13.3 | 1.7 | 11.8 | 13.6 | 7.6 |
Diluted EPS | Rs | 0.2 | 1.4 | 1.9 | 2.5 | 0.4 | 1.5 | 1.6 | 2.0 |
Diluted EPS (TTM) | Rs | 3.8 | 4.4 | 5.0 | 5.9 | 6.2 | 6.2 | 6.0 | 5.4 |
* Results Consolidated | Source: Company Annual Reports, Regulatory Filings, Equitymaster |
Interim results exclude extraordinary / exceptional items |